MedPath
FDA Approval

Morphine Sulfate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Hospira, Inc.
DUNS: 141588017
Effective Date
December 26, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Morphine(50 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Hospira, Inc.

Hospira, Inc.

827731089

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Morphine sulfate

Product Details

NDC Product Code
0409-2022
Application Number
NDA202515
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
December 28, 2023
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACTQuantity: 0.2 mg in 1 mL
MorphineActive
Code: X3P646A2J0Class: ACTIBQuantity: 50 mg in 1 mL
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACTQuantity: 0.8 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT

Morphine Sulfate

Product Details

NDC Product Code
0409-1896
Application Number
NDA202515
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
December 28, 2023
MorphineActive
Code: X3P646A2J0Class: ACTIBQuantity: 50 mg in 1 mL
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACTQuantity: 0.2 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACTQuantity: 0.8 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath